Servicios Personalizados
Revista
Articulo
Español (pdf)
Articulo en XML
Referencias del artículo
Traducción automática
Enviar articulo por emailIndicadores
Citado por SciELO
Links relacionados
Similares en
SciELO
Compartir
Permalink
Revista de Gastroenterología del Perú
versión impresa ISSN 1022-5129
Resumen
LI SALVATIERRA, Bruno; CALIXTO-AGUILAR, Lesly; RAMOS-CASTILLO, Wilder y CHACALTANA MENDOZA, Alfonso. Effectiveness and safety of endosonography-guided liver biopsy in liver disease at a level III public hospital. Rev. gastroenterol. Perú [online]. 2023, vol.43, n.4, pp.341-347. Epub 20-Dic-2023. ISSN 1022-5129. http://dx.doi.org/10.47892/rgp.2023.434.1592.
Parenchymal liver diseases are commonly evaluated by laboratory and imaging studies. However, in some cases a liver biopsy is required. Endoscopic ultrasonography-guided liver biopsy (EUS-LB) has been reported as a procedure with high diagnostic yield (90-100%) with low adverse event profile, but there are not studies which report about the experience and technique in our country.
Objective:
Determinate the effectiveness and the safety of endosonography-guided liver biopsy in liver parenchymal disease.
Materials and methods:
A prospective study was conducted at a III-2 level of care Public Hospital in Lima, Peru. It included patients over 18 years of age with suspicion of parenchymal liver disease who underwent EUS-LB for study hepatic parenchymal disease since March of 2018 to October of 2022.
Results:
The diagnostic yield of the biopsies was 77.02%, with a mean length of the sample of 13.98mm (standard deviation 7.34) and a median of 8 complete portal spaces (0-50). Only 31.25% of the procedures were performed with a fine needle biopsy (FNB), finding a significant difference between the type of needle and the diagnostic yield (p=0.01). The most common histopathological diagnosis was autoinmune hepatitis. There were 2.08% of post-procedure complications.
Conclusions:
EUS-LB for the diagnosis of liver parenchymal disease had a diagnostic yield close to 80% in our region with a low profile of adverse events. However, more prospectives studies with a larger number of patients are required.
Palabras clave : Endosonography; Liver; Biopsy, fine-needle aspiration; Biopsy, fine-needle.
